Company Data

DiaMedica Therapeutics Inc.

Ticker
DMAC
Current Price
$3.63 -1.09%
Market Cap
$155.7M
Price Target
Refer to Report
Volume
82.7K
52wk Range
$2.98 - $6.8184
Advanced Market Data

Overview

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. It is principally engaged in the business activity of developing treatments for unmet clinical need or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy